Canopy Growth (CGC) EBT (QoQ) (2019 - 2025)
Canopy Growth (CGC) EBT (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,122.94% |
| Sep 30, 2025 | 89.24% |
| Dec 31, 2024 | 14.69% |
| Sep 30, 2024 | -10.30% |
| Jun 30, 2024 | 34.18% |
| Mar 31, 2024 | 30.14% |
| Dec 31, 2023 | -71.12% |
| Sep 30, 2023 | -1,384.96% |
| Jun 30, 2023 | 98.58% |
| Mar 31, 2023 | -165.93% |
| Dec 31, 2022 | -16.46% |
| Sep 30, 2022 | 91.19% |
| Jun 30, 2022 | -294.75% |
| Mar 31, 2022 | -352.06% |
| Dec 31, 2021 | -491.27% |
| Sep 30, 2021 | -104.86% |
| Jun 30, 2021 | 175.05% |
| Mar 31, 2021 | 34.29% |
| Dec 31, 2020 | -799.56% |
| Sep 30, 2020 | 23.96% |